Table 2 Treatment characteristics between SBRT and CF-EBRT
Variable | SBRT (n = 36) | CF-EBRT (n = 17) |
|---|---|---|
Location, n (%) | ||
Thorax | 27 (75 %) | 9 (53 %) |
Skin & Soft Tissue | 3 (8.3 %) | 5 (29 %) |
Abdomen | 6 (16.7 %) | 3 (18 %) |
Median Dose Per Fraction (range, Gy) | 10 (5–25) | 4 (2.5–4) |
Median Tumor Size (range, mm)* | 21 (4–87) | 23 (15–57) |
Gross Tumor Volume (GTV) (range, cm3) | 5.14 (0.93–184.07) | - |
Planned Tumor Volume (PTV) (range, cm3) | 20.01 (6.00–295.51) | - |
Biological Effective Dose (BED) (range) | 216.67 (66.67–460) | 60.00 (46.67–100.83) |
Systemic Therapy Prior to Radiation, n (%) | ||
Yes | 26 (72 %) | 12 (71 %) |
No | 10 (28 %) | 5 (29 %) |
Systemic Therapy After Radiation, n (%) | ||
Yes | 20 (55 %) | 10 (59 %) |
No | 16 (45 %) | 7 (41 %) |